Zomedica Pharmaceuticals Corp. (NYSE:ZOM) has a beta value of -0.28 and has seen 14,309,815 shares traded in the last trading session. The company, currently valued at $60.96 Million, closed the last trade at $0.11 per share which meant it lost $0 on the day or 2.69% during that session. The ZOM stock price is -353.64% off its 52-week high price of $0.499 and 4.55% above the 52-week low of $0.105. If we look at the company’s 10-day average daily trading volume, we find that it stood at 20.78 Million shares traded. The 3-month trading volume is 52.32 Million shares.
The consensus among analysts is that Zomedica Pharmaceuticals Corp. (ZOM) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 1 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $0.
Zomedica Pharmaceuticals Corp. (NYSE:ZOM) trade information
Sporting 2.69% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, Sep 08 when the ZOM stock price touched $0.1245 or saw a rise of 11.08%. Year-to-date, Zomedica Pharmaceuticals Corp. shares have moved -66.56%, while the 5-day performance has seen it change -3.15%. Over the past 30 days, the shares of Zomedica Pharmaceuticals Corp. (NYSE:ZOM) have changed -17.08%. Short interest in the company has seen 14.3 Million shares shorted with days to cover at 0.27.
Wall Street analysts have a consensus price target for the stock at $0.5, which means that the shares’ value could jump 354.55% from current levels. The projected low price target is $0.5 while the price target rests at a high of $0.5. In that case, then, we find that the current price level is +354.55% off the targeted high while a plunge would see the stock lose 354.55% from current levels.
Zomedica Pharmaceuticals Corp. (ZOM) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -28.5% over the past 5 years. Earnings growth for 2020 is a modest -4.5%.